The classic website will no longer be available as of June 25, 2024. Please use the modernized

Key Record Dates Identifier: NCT05232071
Brief Title: Placebo-controlled, Proof-of-concept Study to Evaluate the Safety and Efficacy of Lanifibranor Alone and in Combination With SGLT2 Inhibitor EmpaGliflozin in patiEnts With NASH and Type 2 Diabetes Mellitus (LEGEND)

First Submitted : January 26, 2022
First Submitted that Met QC Criteria : February 8, 2022
First Posted : February 9, 2022

Last Update Submitted that Met QC Criteria : February 22, 2024
Last Update Posted : February 23, 2024